Company Name Skylight Biotech Inc,
Company Representative Takushi NAKAJIMA
Incorporated August 28, 2002
Head Office / Analysis Center 100-4 Sunada Iijima-aza
Akita 011-0911, Japan
Tokyo Service Center 4th Floor, Imagics Building
2-10-11 Kajicho, Chiyoda-ku
Tokyo 101-0044, Japan
Capital 462 million yen
Stockholder Immuno-Biological Laboratories Co., Ltd.
Bank of Account Sumitomo Mitsui Banking Corporation, Mizuho Bank,
Bank of Tokyo-Mitsubishi UFJ, Resona Bank, Akita Bank


Aug, 2002
Incorporated in Akita City
Sep, 2002

Acquired an exclusive license to the technology of 'Gene Expression Data Processing Method and Program' (PATPEND No. 2002-66946)

Launched SuperNORM service
Feb, 2003
Relocated the Head Office to Challenge Office Akita in Akita City
Mar, 2003
Acquired an exclusive license to the technology of 'Lipoprotein Analysis Method and Program' (Japan Patent No. 3899041)
Jun, 2003
Series A round of financing
Jul, 2003
Launched LipoSEARCH service
Feb, 2004
Relocated the Head office and established the Tokyo Service Center
Aug, 2004
Series B round of financing
Oct, 2004
Started a collaborative research with Yamato Seiwa Hospital on the lipid metabolism of patients who underwent heart surgery
Nov, 2004
Relocated the Tokyo Service Center
Dec, 2004
Commenced collaborations with Nippon Veterinary and Animal science University (currently Nippon Veterinary and Life Science University) on feline and canine lipid metabolism.
May, 2005
Started a collaborative research with Clinical Preventive Center of St. Luke’s International Hospital on the lipid metabolism of those who had a complete medical checkup.
Oct, 2006
Integrated the head office and the Analysis Center and relocated the Tokyo Service Center
Jan, 2007
Series C round of financing